Status:

COMPLETED

HIRREM Developmental Study

Lead Sponsor:

Wake Forest University Health Sciences

Conditions:

Sleep Initiation and Maintenance Disorders

Anxiety

Eligibility:

All Genders

11+ years

Phase:

NA

Brief Summary

The purpose of this study is to explore the functional and physiological effects associated with the use of High-resolution, relational, resonance-based, electroencephalic mirroring (HIRREM), as suppl...

Eligibility Criteria

Inclusion

  • Male and female adults and children aged 11 years and older.
  • Subjects who are over the age of 18 must be able to give informed consent. Children must be able to sign an assent form and have a signed parental permission form.
  • Subjects must have the ability to comply with basic instructions and be able to sit still comfortably with the sensor leads attached.
  • Subjects previously diagnosed with a neurologic, cardiovascular, or psychophysiological disease such as attention deficit hyperactivity disorder, Asperger Syndrome, chronic pain, dyslexia, depression, insomnia, migraines, anxiety, PTSD, substance abuse disorder, traumatic brain injury, and others.

Exclusion

  • Subjects who fail to meet inclusion criteria.
  • Subjects who are unable, unwilling, or incompetent to provide informed consent, assent and/or parental permission.
  • Subjects physically unable to come to the study visits.
  • Subjects with a known seizure disorder.
  • Subjects with severe bilateral hearing impairment (HIRREM requires the use of headphones).
  • Subjects receiving ongoing treatment with opiate, benzodiazepine, anti-psychotic or sleep medications, as well as some anti-depressants or stimulants, except those cases deemed acceptable by the principal investigator.
  • Subjects with anticipated and ongoing use of recreational drugs except when deemed acceptable by the principal investigator.

Key Trial Info

Start Date :

August 23 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 25 2018

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT02709369

Start Date

August 23 2011

End Date

October 25 2018

Last Update

December 24 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Neurology, Wake Forest School of Medicine

Winston-Salem, North Carolina, United States, 27157